ReviewBiosensors2025
AI-Empowered Electrochemical Sensors for Biomedical Applications: Technological Advances and Future Challenges.
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Review
- Carbon Dot-Based Electrochemical and Optical Sensors for Pharmaceutical Analysis and Point-of-Care Diagnostics.Biosensors · 2026Review
- DNAzyme-Based Nanostructures for Dynamic Cell Regulation and Sensing.ChemistryOpen · 2026Review
- From Drops to Decisions: AI/ML-Driven Biofluidics for Clinical Diagnostics and Healthcare Intelligence.Analytical chemistry · 2026Review
- Advances in biosensors for bacterial detection and identification.World journal of microbiology & biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Biomarkers play a pivotal role in disease diagnosis, therapeutic efficacy evaluation, prognostic assessment, and drug screening. However, the trace concentrations of these markers in complex physiological environments pose significant challenges to efficient detection. It is necessary to avoid interference from non-specific signals, which may lead to misjudgment of other substances as biomarkers and affect the accuracy of detection results. With the rapid advancements in electrochemical technologies and artificial intelligence (AI) algorithms, intelligent electrochemical biosensors have emerged as a promising approach for biomedical detection, offering speed, specificity, high sensitivity, and accuracy. This review focuses on elaborating the latest applications of AI-empowered electrochemical biosensors in the biomedical field, including disease diagnosis, treatment monitoring, drug development, and wearable devices. AI algorithms can further improve the accuracy, sensitivity, and repeatability of electrochemical sensors through the screening and performance prediction of sensor materials, as well as the feature extraction and noise reduction suppression of sensing signals. Even in complex physiological microenvironments, they can effectively address common issues such as electrode fouling, poor signal-to-noise ratio, chemical interference, and matrix effects. This work may provide novel insights for the development of next-generation intelligent biosensors for precision medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.